Trials / Conditions / Estrogen Receptor-Positive Breast Carcinoma

Estrogen Receptor-Positive Breast Carcinoma

10 registered clinical trials studyying Estrogen Receptor-Positive Breast Carcinoma — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy Wi NCT07391774	National Cancer Institute (NCI)	Phase 3
Suspended	Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer NCT07136493	City of Hope Medical Center	N/A
Suspended	Testing Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial NCT06671912	Alliance for Clinical Trials in Oncology	Phase 3
Recruiting	Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoin NCT06450873	Mayo Clinic	Phase 2
Recruiting	Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial NCT06184750	National Cancer Institute (NCI)	Phase 2
Suspended	High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breas NCT06538389	City of Hope Medical Center	Phase 2
Recruiting	Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Rece NCT06260033	City of Hope Medical Center	Phase 2
Recruiting	Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy NCT06401889	Mayo Clinic	—
Recruiting	Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase In NCT06028022	Mayo Clinic	Phase 2
Suspended	Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance NCT06008158	City of Hope Medical Center	Phase 2